Clinical trial
A Prospective, Multi-center, Post-market Registry Study Evaluating Safety and Effectiveness of the Microport™CardioFlow VitaFlow™Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
NCT04414865 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Post-market Registry Study Evaluating Safety and Effectiveness of the Microport™CardioFlow VitaFlow™Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 26, 2020
- Completion date
- December 30, 2027
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.